Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance

European Journal of Clinical Investigation

Volumn 44, Issue 7, 2014, Pages 627-633

  Rametta, Raffaela ^a   Ruscica, Massimiliano ^a   Dongiovanni, Paola ^a   Macchi, Chiara ^a   Fracanzani, Anna L ^a   Steffani, Liliana ^a   Fargion, Silvia ^a   Magni, Paolo ^a   Valenti, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Fetuin A; Insulin resistance; Nonalcoholic fatty liver disease; Pnpla3; Steatosis

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; CHOLESTEROL; FETUIN A; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PROTEIN; PROTEIN PNPLA3 I148M; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; FATTY ACID; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; FATTY LIVER; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPONECTIN; ALPHA-2-HS-GLYCOPROTEIN; CROSS-SECTIONAL STUDIES; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPASE; LIPID METABOLISM; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84903395516     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12280     Document Type: Article

References (29)

1. Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 2003;376:135-45.
2. Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, Goustin AS. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 1993;7:1445-55.
3. Mathews ST, Srinivas PR, Leon MA, Grunberger G. Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci 1997;61:1583-92.
4. Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000;164:87-98.
5. Schmidt W, Poll-Jordan G, Loffler G. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosteron, and cyclic AMP. J Biol Chem 1990;265:15489-95.
6. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Haring HU. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 2008;3:e1765.
7. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002;51:2450-8.
8. Mathews ST, Rakhade S, Zhou X, Parker GC, Coscina DV, Grunberger G. Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochem Biophys Res Commun 2006;350:437-43.
9. Siddiq A, Lepretre F, Hercberg S, Froguel P, Gibson F. A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes 2005;54:2477-81.
10. Dahlman I, Eriksson P, Kaaman M, Jiao H, Lindgren CM, Kere J et al. alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 2004;47:1974-9.
11. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-7.
12. Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006;29:468.
13. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006;113:1760-7.
14. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:4479-85.
15. Yilmaz Y, Yonal O, Kurt R, Ari F, Oral AY, Celikel CA. Serum fetuin A/a2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. Ann Clin Biochem 2010;47:549-53.
16. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Increased Fetuin-A concentrations in impaired glucose tolerance with or without non alcoholic fatty liver disease, but not impaired fasting glucose. J Clin Endocrinol Metab 2012;97:4717-23.
17. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-5.
18. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P et al. Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1209-17.
19. Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009;52(6):1056-60.
20. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010;52:1274-80.
21. Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S et al. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol 2013;19:6969-78.
22. Valenti L, Rametta R, Ruscica M, Dongiovanni P, Steffani L, Motta BM. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol 2012;12:111.
23. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26(3):439-51.
24. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313-21.
25. Simera I, Mother D, Hoey J, Schultz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
26. Xu Y, Xu M, Bi Y, Song A, Huang Y, Liu Y. Serum fetuin-A is correlated with metabolic syndrome in middleaged and elderly Chinese. Atherosclerosis 2011;216:180-6.
27. Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb 2010;17:925-33.
28. Hyysalo J, Gopalacharyulu P, Bian H, Hyotylainen T, Leivonen M, Jaser N. Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity. Diabetes 2014;63:312-22.
29. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011;53:1883-94.